{
    "nctId": "NCT05479409",
    "briefTitle": "Neoadjuvant Radiation in Locally Advanced Breast Cancer",
    "officialTitle": "Effect of Neoadjuvant Radiation and Prediction of Response to Treatment in Locally Advanced Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Pathological response rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically or cytologically confirmed locally advanced breast carcinoma\n* Inoperable with with 4-6 courses of prior chemotherapy\n* No contradiction of radiation or chemo-radiotherapy\n* Patients should have the ability to understand and the willingness to sign a written informed consent document\n* Signed informed consent must be obtained prior to any study specific procedures\n\nExclusion Criteria:\n\n* Other prior or concurrent malignancy except adequately treated squamous cell or basal cell skin cancer or contralateral breast DCIS\n* Coagulation disorders\n* Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, and cardiac arrhythmia\n* Serious underlying medical illness with life expectancy less than 2 years.\n* Any condition that is unstable or could jeopardize the safety of the patient and their compliance in the study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}